Literature DB >> 24286381

Replacing the thorough QT study: reflections of a baby in the bath water.

Robert B Kleiman1, Rashmi R Shah, Joel Morganroth.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24286381      PMCID: PMC4137815          DOI: 10.1111/bcp.12296

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  29 in total

1.  The cost-effectiveness of drug regulation: the example of thorough QT/QTc studies.

Authors:  J C Bouvy; M A Koopmanschap; R R Shah; H Schellekens
Journal:  Clin Pharmacol Ther       Date:  2011-12-28       Impact factor: 6.875

2.  Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.

Authors:  Shaobin Jia; Jiangfan Lian; Donglin Guo; Xiaolin Xue; Chinmay Patel; Lin Yang; Zuyi Yuan; Aiqun Ma; Gan-Xin Yan
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 3.  Early investigation of QTc liability: the role of multiple ascending dose (MAD) study.

Authors:  Rashmi R Shah; Joel Morganroth
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

Review 4.  Dealing with global safety issues : was the response to QT-liability of non-cardiac drugs well coordinated?

Authors:  Norman Stockbridge; Joel Morganroth; Rashmi R Shah; Christine Garnett
Journal:  Drug Saf       Date:  2013-03       Impact factor: 5.606

Review 5.  Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval).

Authors:  Rashmi R Shah; Joel Morganroth; Devron R Shah
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

6.  Transmural dispersion of repolarization as a preclinical marker of drug-induced proarrhythmia.

Authors:  Tamer H Said; Lance D Wilson; Darwin Jeyaraj; Anthony A Fossa; David S Rosenbaum
Journal:  J Cardiovasc Pharmacol       Date:  2012-08       Impact factor: 3.105

7.  Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.

Authors:  Gary R Mirams; Yi Cui; Anna Sher; Martin Fink; Jonathan Cooper; Bronagh M Heath; Nick C McMahon; David J Gavaghan; Denis Noble
Journal:  Cardiovasc Res       Date:  2011-02-07       Impact factor: 10.787

Review 8.  Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing.

Authors:  Gary R Mirams; Mark R Davies; Yi Cui; Peter Kohl; Denis Noble
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

9.  Computational assessment of drug-induced effects on the electrocardiogram: from ion channel to body surface potentials.

Authors:  Nejib Zemzemi; Miguel O Bernabeu; Javier Saiz; Jonathan Cooper; Pras Pathmanathan; Gary R Mirams; Joe Pitt-Francis; Blanca Rodriguez
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

10.  Evaluation of an in silico cardiac safety assay: using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge.

Authors:  Kylie A Beattie; Chris Luscombe; Geoff Williams; Jordi Munoz-Muriedas; David J Gavaghan; Yi Cui; Gary R Mirams
Journal:  J Pharmacol Toxicol Methods       Date:  2013-04-25       Impact factor: 1.950

View more
  4 in total

1.  Balancing the Need for Personalization of QT Correction and Generalization of Study Results: Going Beyond Thorough QT Studies.

Authors:  Igor Diemberger; Emanuel Raschi; Gianluca Trifirò
Journal:  Clin Drug Investig       Date:  2017-10       Impact factor: 2.859

2.  Prediction of arrhythmia susceptibility through mathematical modeling and machine learning.

Authors:  Meera Varshneya; Xueyan Mei; Eric A Sobie
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

3.  A web portal for in-silico action potential predictions.

Authors:  Geoff Williams; Gary R Mirams
Journal:  J Pharmacol Toxicol Methods       Date:  2015-05-09       Impact factor: 1.950

4.  Prediction of Thorough QT study results using action potential simulations based on ion channel screens.

Authors:  Gary R Mirams; Mark R Davies; Stephen J Brough; Matthew H Bridgland-Taylor; Yi Cui; David J Gavaghan; Najah Abi-Gerges
Journal:  J Pharmacol Toxicol Methods       Date:  2014-07-31       Impact factor: 1.950

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.